SYMPICITY HTN-3's Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss
Experts grappled with how to understand the positive findings given that the trial missed its primary endpoint at 6 months.
Source: tctmd.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Global Symplicity. Real-time updates on events, politics, business and more.